製品番号: HY-100599

ウロリチン A

(別名: Urolithin A)

48 Cited Publications

カスタマーレビュー

Based on 48 publication(s) in Google Scholar

Urolithin A, a gut-microbial metabolite of ellagic acid, exerts anti-inflammatory, antiproliferative, and antioxidant properties. Urolithin A induces autophagy and apoptosis, suppresses cell cycle progression, and inhibits DNA synthesis.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

純度: 99.71%
CAS 番号: 1143-70-0
分子式: C₁₃H₈O₄
分子量:228.20

保管条件:

Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 1 year , -20°C, 6 months

Urolithin A 構造式

CAS 番号: 1143-70-0

容量

価格（税別）

在庫状況

数量

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性
- 製品説明
- IC₅₀ & Target
- 体外実験
- 体内実験
- 臨床実験
化学情報
Publications (48)
溶剤 & 溶解度
- 体外
- 体内
プロトコル
純度とドキュメンテーション
参考文献
Help & FAQs
関連分類
Bioz

生物活性

製品説明

IC₅₀ & Target

Microbial Metabolite

DNA/RNA Synthesis アイソフォーム固有の製品をすべて表示 :

Endogenous Metabolite アイソフォーム固有の製品をすべて表示 :

体外実験

Micromolar urolithin A concentrations induces both autophagy and apoptosis. Urolithin A suppresses cell cycle progression and inhibited DNA synthesis in human sw620 colorectal cancer cells^[2].
Urolithin A shows antiproliferative effects and inhibits T24 and Caco-2 cell growth with IC₅₀s of 43.9 and 49 μM, respectively^[3].
Urolithin A exerts a dose- and time-dependent significant arrest at G2/M and S phases after treatments with 50 and 100 μM at 24 and 48 h compared to control cells. It induces cell apoptosis with 50 and 100 μM ^[4].
Urolithin A shows potent antiproliferative activity on HepG2 cells. When cell death is induced by Urolithin A, the expression of β-catenin, c-Myc and Cyclin D1 are decreased and TCF/LEF transcriptional activation is notably down-regulated. Urolithin A also increases protein expression of p53, p38-MAPK and caspase-3, but suppresses expression of NF-κB p65 and other inflammatory mediators^[5].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

体内実験

The volume of paw edema is reduced at 1 h after oral administration of urolithin A. In addition, plasma in treated mice exhibited significant oxygen radical antioxidant capacity (ORAC) scores with high plasma levels of the unconjugated form at 1 h after oral administration of urolithin A^[6].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

臨床実験

NCT Number	Sponsor	Condition	Start Date	Phase A549
NCT01329991	Plexxikon\|		2011-05	PHASE1

化学情報

CAS 番号 1143-70-0
性状 Solid
分子量 228.20
分子式 C₁₃H₈O₄
Color Light yellow to brown
SMILES

O=C1C2=CC(O)=CC=C2C3=CC=C(O)C=C3O1
別名

Urolithin A
Structure Classification
- Phenols
- Monophenols
- Phenols
- Polyphenols
Initial Source
- Endogenous metabolite
- Human Gut Microbiota Metabolites
- Microorganisms
gut bacteria
輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	1 year
	-20°C	6 months

Publications (48)

All IFWBIn Vivo Efficacy StudyIn Vivo Imaging

Sort by:

Journal Impact Factor

Mater Today

2026 Jan 7;92:453-472.
Mol Cell

The human antibacterial factor APOL3 couples lysosomal damage to mitochondrial DNA efflux and type I IFN induction. [Abstract]

2026 Feb 24:S1097-2765(26)00071-7. PMID: 41742416
Nat Commun

Osteocyte-derived extracellular vesicles mediate the bone-to-cartilage crosstalk and promote osteoarthritis progression. [Abstract]

2025 May 22;16(1):4746. PMID: 40399261
Autophagy

Impaired mitophagy contributes to osteogenesis and mineralization disorders in fibrous dysplasia. [Abstract]

2026 Mar 15:1-22. PMID: 41803635
J Nanobiotechnology

Osteoblastic ferroptosis inhibition by small-molecule promoting GPX4 activation for peri-prosthetic osteolysis therapy. [Abstract]

2024 Dec 18;22(1):758. PMID: 39696565
J Nanobiotechnology

PINK1/TAX1BP1-directed mitophagy attenuates vascular endothelial injury induced by copper oxide nanoparticles. [Abstract]

2022 Mar 19;20(1):149. PMID: 35305662

Urolithin A purchased from MedChemExpress. Usage Cited in: J Nanobiotechnology. 2022 Mar 19;20(1):149. [Abstract]

Urolithin A (100 μM; 12 h). Representative fluorescence images of EA.hy926 cell line stable expressing GFP-LC3 and Mito-DsRed.

Urolithin A purchased from MedChemExpress. Usage Cited in: J Nanobiotechnology. 2022 Mar 19;20(1):149. [Abstract]

UA (100 μM; 24 h). The protein levels of TOM20, VDAC1, ATP5B and TIM23 in CuONPs-treated EA.hy926 cells were analyzed and quantified by Western blotting.

Urolithin A purchased from MedChemExpress. Usage Cited in: J Nanobiotechnology. 2022 Mar 19;20(1):149. [Abstract]

Representative TEM images of mice abdominal aorta dissected from CuONPs-treated mice. Mice were treated with UA (30 mg/kg; 10 days) by intragastric gavage and then intratracheally instilled with CuONPs (5 mg/kg) at day 7.
J Hazard Mater

Environmentally relevant concentrations of perfluorobutane sulfonate impair locomotion behaviors and healthspan by downregulating mitophagy in C. elegans. [Abstract]

2024 Sep 23:480:135938. PMID: 39326150
J Neuroinflammation

Protective role of mitophagy on microglia-mediated neuroinflammatory injury through mtDNA-STING signaling in manganese-induced parkinsonism. [Abstract]

2025 Feb 28;22(1):55. PMID: 40022162

Urolithin A purchased from MedChemExpress. Usage Cited in: J Neuroinflammation. 2025 Feb 28;22(1):55. [Abstract]

UA (10 μM; 2 h) pretreatment ameliorated Mn-induced microglial mitophagy suppression.

Urolithin A purchased from MedChemExpress. Usage Cited in: J Neuroinflammation. 2025 Feb 28;22(1):55. [Abstract]

Flow cytometry shows reduced ROS levels in the striatum after UA (2.3 mg/kg; ip; 3 days) pretreatment compared with Mn-treated.
Environ Int

Trimethyltin chloride triggers ferroptosis in myocardial injury: mitochondria-dependent protection by luteolin. [Abstract]

2026 May:211:110262. PMID: 42013553
Cell Death Dis

Activation of HIF-1α C-terminal transactivation domain protects against hypoxia-induced kidney injury through hexokinase 2-mediated mitophagy. [Abstract]

2023 May 24;14(5):339. PMID: 37225700
Phytomedicine

Kakkalide promotes spinal cord injury repair by regulating microglial M2 polarization via mitophagy. [Abstract]

2026 Apr:153:157985. PMID: 41720005
Free Radic Biol Med

Urolithin A protects against domoic acid-induced cognitive deficits via promoting estrogen receptor-α-mediated mitochondrial biogenesis signaling in mice. [Abstract]

2025 Aug 14:240:296-313. PMID: 40818743
J Headache Pain

Proteomics profiling reveals mitochondrial damage in the thalamus in a mouse model of chronic migraine. [Abstract]

2023 Sep 5;24(1):122. PMID: 37667199
Redox Rep

Urolithin A alleviates vascular remodeling through mitochondrial SIRT3-mediated SOD2 deacetylation and antioxidation in hypertensive rats. [Abstract]

2026 Dec;31(1):2622255. PMID: 41645805
Food Biosci

2024 Feb, 57, 103549.
Food Biosci

2023 Jul 31, 102983.
ACS Biomater Sci Eng

Microbiome Metabolite-Incorporated Lipid Nanoparticles Augment CD8+ T Cell Memory Potential and Immunity for mRNA Cancer Vaccines. [Abstract]

2025 Jul 14;11(7):4254-4265. PMID: 40490465
Radiother Oncol

Mitophagy induction improves salivary gland stem/progenitor cell function by reducing senescence after irradiation. [Abstract]

2024 Jan:190:110028. PMID: 38007043
Commun Biol

Activating Parkin-dependent mitophagy alleviates oxidative stress, apoptosis, and promotes random-pattern skin flaps survival. [Abstract]

2022 Jun 22;5(1):616. PMID: 35732814
Int J Mol Sci

Urolithin A Protects Porcine Oocytes from Artificially Induced Oxidative Stress Damage to Enhance Oocyte Maturation and Subsequent Embryo Development. [Abstract]

2025 Mar 26;26(7):3037. PMID: 40243704
Int J Mol Sci

Mitophagy Regulates the Circadian Rhythms by Degrading NR1D1 in Simulated Microgravity and Isolation Environments. [Abstract]

2024 Apr 29;25(9):4853. PMID: 38732079
Int Immunopharmacol

Urolithin a attenuates rheumatoid arthritis by inhibiting inflammation and pyroptosis in fibroblasts via the AMPK/ NF-κB signaling pathway. [Abstract]

2025 Apr 10:155:114604. PMID: 40215775
Int Immunopharmacol

Urolithin A enhances diabetic wound healing: Insights from parkin-mediated mitophagy in endothelial progenitor cells. [Abstract]

2025 Apr 8:155:114572. PMID: 40203794
Int Immunopharmacol

Urolithin A alleviates NLRP3 inflammasome activation and pyroptosis by promoting microglial mitophagy following spinal cord injury. [Abstract]

2025 Jan 18:148:114057. PMID: 39827665
Int Immunopharmacol

The ellagitannin metabolite urolithin C attenuated cognitive impairment by inhibiting neuroinflammation via downregulation of MAPK/NF-kB signaling pathways in aging mice. [Abstract]

2024 Sep 19;142(Pt B):113151. PMID: 39303538
J Inflamm Res

Apigenin Suppresses NLRP3 Inflammasome Activation and Pyroptosis and Promotes Functional Recovery by Promoting Mitophagy in Experimental Spinal Cord Injured Rats. [Abstract]

2025 Oct 8:18:13965-13984. PMID: 41084615
Toxics

Mitophagy Protects Against Cisplatin-Induced Injury in Granulosa Cells. [Abstract]

2025 Apr 23;13(5):332. PMID: 40423411
Sci Rep

Urolithin A blocks colorectal cancer progression by AKT1 inhibition-driven immune activation. [Abstract]

2026 Apr 1;16(1):15438. PMID: 41922440
J Biol Chem

The FSH-mTOR-CNP signaling axis initiates follicular antrum formation by regulating tight junction, ion pumps, and aquaporins. [Abstract]

2023 Aug;299(8):105015. PMID: 37414146
World J Stem Cells

Urolithin a alleviates oxidative stress-induced senescence in nucleus pulposus-derived mesenchymal stem cells through SIRT1/PGC-1α pathway. [Abstract]

2021 Dec 26;13(12):1928-1946. PMID: 35069991
Biology (Basel)

Urolithin A Protects Ovarian Reserve Via Inhibiting PI3K/Akt Signaling and Preventing Chemotherapy-Induced Follicle Apoptosis. [Abstract]

2025 Jul 8;14(7):829. PMID: 40723388
J Neurosci Res

Astrocytic HSP60 Deletion Induced Astrocyte Senescence and Inhibited Neuroregeneration via Modulating the S1P/Truncated-BDNF Pathway. [Abstract]

2025 Jun;103(6):e70054. PMID: 40448367
Cancer Res Commun

Remodeling of Stromal Immune Microenvironment by Urolithin A Improves Survival with Immune Checkpoint Blockade in Pancreatic Cancer. [Abstract]

2023 Jul 12;3(7):1224-1236. PMID: 37448553
Cell Stress Chaperones

Urolithin A induces cell cycle arrest and apoptosis by inhibiting Bcl-2, increasing p53-p21 proteins and reactive oxygen species production in colorectal cancer cells. [Abstract]

2021 May;26(3):473-493. PMID: 33666815
mSphere

Effect of urolithin A on intracellular survival of Mycobacterium tuberculosis by regulating AKT-FOXO1-mediated autophagy. [Abstract]

2025 Apr 10:e0006125. PMID: 40207917
Naunyn Schmiedebergs Arch Pharmacol

Urolithin A exerts anti-tumor effects on gastric cancer via activating autophagy-Hippo axis and modulating the gut microbiota. [Abstract]

2024 Sep;397(9):6633-6645. PMID: 38489081
Mol Immunol

Gelatin enhances bacteria-phagocytosis via a ROS-mitochondria-STING axis in differentiated human macrophage-like U937 cells. [Abstract]

2025 Oct:186:48-62. PMID: 40815890
Arch Biochem Biophys

Silibinin alleviates ferroptosis of rat islet β cell INS-1 induced by the treatment with palmitic acid and high glucose through enhancing PINK1/parkin-mediated mitophagy. [Abstract]

2023 Jul 15:743:109644. PMID: 37245586
Cell Biochem Funct

Urolithin A affects cellular migration and modulates matrix metalloproteinase expression in colorectal cancer cells. [Abstract]

2024 Apr;42(3):e4019. PMID: 38622949
Sports Med Health Sci

Sulforaphane, Urolithin A, and ZLN005 induce time-dependent alterations in antioxidant capacity, mitophagy, and mitochondrial biogenesis in muscle cells. [Abstract]

2024 Apr 4;7(1):16-27. PMID: 39649792
Vet Parasitol

Role of autophagy in resistance to ivermectin in Haemonchus contortus. [Abstract]

2025 Jan:333:110360. PMID: 39616807
Connect Tissue Res

Collagen I alleviates UVB-induced oxidative DNA damage and inhibits YAP-p73 apoptotic pathway in human keratinocytes HaCaT. [Abstract]

2026 May;67(3):243-257. PMID: 41700367
Neurochirurgie

Urolithin A alleviates early brain injury after subarachnoid hemorrhage by regulating the AMPK/mTOR pathway-mediated autophagy. [Abstract]

2023 Aug 18;69(5):101480. PMID: 37598622
Science Essence Journal

2025.
SSRN

2025 Aug 7.
bioRxiv

The antibacterial factor APOL3 couples lysosomal damage to mitochondrial DNA efflux and type I IFN induction. [Abstract]

2025 May 19:2025.05.16.654477. PMID: 40475483
Phytomed Plus

2023 Nov 4, 100495.
Research Square Preprint

2021 Oct.

溶剤 & 溶解度

体外:

DMSO : 50 mg/mL (219.11 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

4.3821 mL

21.9106 mL

43.8212 mL

5 mM

0.8764 mL

4.3821 mL

8.7642 mL

10 mM

0.4382 mL

2.1911 mL

4.3821 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

体内:

Select the appropriate dissolution method based on your experimental animal and administration route.

Stock Solution Working Solution

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline

Solubility: ≥ 2.5 mg/mL (10.96 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)

Solubility: 2.5 mg/mL (10.96 mM); Suspended solution; Need ultrasonic

This protocol yields a suspended solution of 2.5 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

Protocol 3

Add each solvent one by one: 10% DMSO 90% Corn Oil

Solubility: ≥ 2.5 mg/mL (10.96 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

Working Solution

For the following dissolution methods, please prepare the working solution directly:

It is recommended to prepare fresh solutions and use them promptly within a short period of time.

The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 50% PEG300 50% Saline

Solubility: 5 mg/mL (21.91 mM); Suspended solution; Need ultrasonic

Protocol 2

Add each solvent one by one: 15% Cremophor EL 85% Saline

Solubility: 7.35 mg/mL (32.21 mM); Suspended solution; Need ultrasonic

Protocol 3

Add each solvent one by one: 0.5% CMC/saline water

Solubility: 5 mg/mL (21.91 mM); Suspended solution; Need ultrasonic

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage Dosage
mg/kg
Animal Weight (Per Animal) Animal Weight (Per Animal)
g
Dosing Volume (Per Animal) Dosing Volume (Per Animal)
μL
Number of Animals Number of Animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

%
DMSO +

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
%
+
+
%
Tween-80 + +
%
Saline +

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Working solution concentration: 0.22 mg/mL

プロトコル

Cell Assay^[2]

Human colon cancer cells HT-29 are treated for 24 and 48 h at 100 and 50 μM of Urolithin A and Iso Urolithin A aglycones and their glucuronide conjugates. Cell viability and proliferation are measured using a TC10 automated cell counter with the addition of Trypan blue for viability determination. IC₅₀ values are determined by MTT assay^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Administration^[4]

Mice: Paw edema is induced in the right hind paw of ICR mice by the subcutaneous injection of 1% λ-carrageenan in pysiological saline (50 μL). The inflammation level is quantified by the volume of paw edema. Urolithin A dissolved in 0.5% carboxymethylcellulose suspension is orally administered to the mice at 1 or 6 h before carrageenan injection. The anti-inflammatory effects of urolithin A on carrageenan-induced edema in mice are analyzed^[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

純度とドキュメンテーション

バッチを選択:

純度: 99.98%

Assay: 99.98%

ee.: 99.98%

データシート (280 KB)
SDS (396 KB)
- English - EN (396 KB)
- Français - FR (396 KB)
- Deutsch - DE (396 KB)
- Norwegian - NO (396 KB)
- Español - ES (396 KB)
- Swedish - SV (396 KB)
- Italian - IT (396 KB)
- Korean - KR (396 KB)
- Portuguese - PT (396 KB)
COA (2659 KB)
元素分析報告書 (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
取扱説明書 (2659 KB)

参考文献

[1]. Gong Z, et al. Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice. [Content Brief]

[2]. Wang Y, et al. In vitro antiproliferative and antioxidant effects of urolithin A, the colonic metabolite of ellagic acid, on hepatocellular carcinomas HepG2 cells. Toxicol In Vitro. 2015 Aug;29(5):1107-15. [Content Brief]

[3]. Zhao W, et al. Metabolite of ellagitannins, urolithin A induces autophagy and inhibits metastasis in human sw620colorectal cancer cells. Mol Carcinog. 2018 Feb;57(2):193-200. [Content Brief]

[4]. Ishimoto H, et al. In vivo anti-inflammatory and antioxidant properties of ellagitannin metabolite urolithin A. Bioorg Med Chem Lett. 2011 Oct 1;21(19):5901-4. [Content Brief]

[5]. Qiu Z, et al. In vitro antioxidant and antiproliferative effects of ellagic acid and its colonic metabolite, urolithins, on human bladder cancer T24 cells. Food Chem Toxicol. 2013 Sep;59:428-37. [Content Brief]

[6]. González-Sarrías A, et al. Antiproliferative activity of the ellagic acid-derived gut microbiota isourolithin A and comparison with its urolithin A isomer: the role of cell metabolism.Eur J Nutr. 2017 Mar;56(2):831-841. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	4.3821 mL	21.9106 mL	43.8212 mL	109.5530 mL
	5 mM	0.8764 mL	4.3821 mL	8.7642 mL	21.9106 mL
	10 mM	0.4382 mL	2.1911 mL	4.3821 mL	10.9553 mL
	15 mM	0.2921 mL	1.4607 mL	2.9214 mL	7.3035 mL
	20 mM	0.2191 mL	1.0955 mL	2.1911 mL	5.4777 mL
	25 mM	0.1753 mL	0.8764 mL	1.7528 mL	4.3821 mL
	30 mM	0.1461 mL	0.7304 mL	1.4607 mL	3.6518 mL
	40 mM	0.1096 mL	0.5478 mL	1.0955 mL	2.7388 mL
	50 mM	0.0876 mL	0.4382 mL	0.8764 mL	2.1911 mL
	60 mM	0.0730 mL	0.3652 mL	0.7304 mL	1.8259 mL
	80 mM	0.0548 mL	0.2739 mL	0.5478 mL	1.3694 mL
	100 mM	0.0438 mL	0.2191 mL	0.4382 mL	1.0955 mL

Keywords

Urolithin A

48 Cited Publications

100 mg お問い合わせ

Subscribe to the

MedChemExpress

Newsletter

製品名:
製品番号:
数量:
日本の代理先をお選びください:

製品名:
CAS 番号:
生物種:
純度:
数量:

ウロリチン A

Apoptosis Compound Library

Cell Cycle/DNA Damage Compound Library

Immunology/Inflammation Compound Library

Metabolism/Protease Compound Library

NF-κB Signaling Compound Library

Natural Product Library

Anti-Cancer Compound Library

Clinical Compound Library

Autophagy Compound Library

Anti-Aging Compound Library

Drug Repurposing Compound Library

Antioxidant Compound Library

Phenols Library

Traditional Chinese Medicine Active Compound Library

Gut Microbial Metabolite Library

Microbial Metabolite Library

Drug Metabolite Library

Targeted Diversity Library

Anti-Cancer Natural Product Library

Anti-inflammatory Traditional Chinese Medicine Active Compound Library

Human Metabolite Library

Anti-Aging Natural Product Library

Mitochondrial Protection Compound Library

Mitochondrial Toxicity Compound Library

Cell Death Library

Radioprotector Library

Bioactive Compound Library Max

Anti-Aging Compound Library Mini

MCE Bioactive Compound Library

Natural Product Library Plus

Drug Repurposing Compound Library Plus

Clinical Compound Library Plus

Natural Product and Natural Product-Like Compound Library

Bioactive Compound Library

Anti-Fibrosis Compound Library

Miao Ethnicity Medicine Compound Library

Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library

RO5 Drug-like Natural Product Library

High-Throughput Bioactive Compound Library

High-Throughput Natural Product Library

Mass Spectrometry Human Metabolite Library

Diarrhea-Related Traditional Chinese Medicine Active Compound Library

Mongolian Medicine Compound Library

Natural Product Diversity Scaffold Library

Lactylation Compound Library

Mass Spectrometry Natural Product Library

MedChemExpress（MCE）の使用を引用している文献 Urolithin A

DNA/RNA Synthesis アイソフォーム固有の製品をすべて表示

Endogenous Metabolite アイソフォーム固有の製品をすべて表示

生物活性

化学情報

Publications (48)

溶剤 & 溶解度

プロトコル

純度とドキュメンテーション

参考文献

Help & FAQs

Complete Stock Solution Preparation Table

Urolithin A 関連分類

HY-100599 関連分類